subject index, volume 1
TRANSCRIPT
Subject Index, Volume 1
A
Adult polycystic kidney disease, with diabetic intercapillary glomerulosclerosis (letter), 32
Albumin, urinary insulin-dependent diabetes and, 76
-maturity onset non-insulin-dependent diabetes and, 132
measurement of, 58 Albuminuria, antihypertensive treatment and, 45 Antihylbertensive treatment, renal function and, 45 Armanni-Ebstein lesion, genesis of, in diabetic
nephropathy, 2
Biopsy, renal, necessity of, in nephropathic diabetic, 1 Blood glucose control, see a lso Metabolic control
correlation with renal histopathology and duration of diabetes, 41
Blood pressure, see a lso Hypertension microalbuminuria and, in maturity onset
non-insulin-dependent diabetes, 132 nephropathy progression and, 53
Blood rheology, glomerular filtration and, nephropathy pathogenesis and, 137
C
Co-morbidity, uremia and, 73 Complications, patient experience and physician
response to, 65 Continuous ambulatory peritoneal dialysis
(CAPD), 11, 20 decreasing insulin requirements with, 16
Continuous subcutaneous insulin infusion (CSlI) and kidney function and size in IDDM patients, 91 and metabolic control in kidney transplanted
insulin-dependent diabetics, 81 Cyclosporine, renal function and, in non-uremic
diabetic recipients of pancreas transplants, 128
D
Diabetic nephropathy, see Nephropathy Diabetic retinopathy, see Retinopathy Dialysis, see Continuous ambulatory peritoneal
dialysis; Hemodialysis Dietary protein, nephropathy and, 37 Double immunofluorescence, glomerular sialic acids
and, 61
E
Enzyme immunoassay, microalbuminuria detection with, 58
F
Factor VIII, near normoglycemia and, in Type I diabetes, 100
G
Glomerular filtration, blood rheology and, nephropathy pathogenesis and, 137
Glomerular filtration rate (GFR), 7 Glomerular injury, in Type II diabetes, obese Zucker rat
model of, 26
Glomerular sialic acids, 61 Glomerulopathy, advanced, new vessel formation in
renal corpuscles in, 122 Glomerulosclerosis
intercapillary, adult polycystic kidney disease with (letter), 32
unilateral nephrectomy and, 107 Glucose reabsorption, renal hypertrophy and, 7 Glycemic control, see Blood glucose control;
Metabolic control
H
Hemodialysis centers, attendance of diabetic patients at, in Central Italy, 4
Hydroflumethiazide, renal function and, 45 Hyperglycemia, nephropathy progression and, 53 Hypertension, see a lso Blood pressure
nephropathy progression and, 53 treatment of, renal function and, 45
I
Immunofluorescence staining, double, glomerular sialic acids and, 61
Insulin, intraperitoneal, CAPD patients given, decreasing insulin requirements in, 16
Insulin-dependent diabetes mellitus, see Type I diabetes
Insulin pump treatment and kidney function and size in IDDM patients, 91 and metabolic control in kidney transplanted insulin-
dependent diabetics, 81 Intercapillary glomerulosclerosis, adult polycystic
kidney disease with (letter), 32 Intraperitoneal insulin, subcutaneous insulin vs., CAPD
patients and, 16 Islet transplants, potential of, 115 Italy, Central, dialysis centers in, attendance of diabetic
patients at, 4
K
Kidney, see Nephropathy; Renal ent r ies
M
Metabolic control kidney transplant and, 81 microalbuminuria and, in maturity onset non-insulin-
dependent diabetes, 132 nephropathy progression and. 53
Metoprolol, renal function and, 45 Microalbuminuria, 132
detection of, 58 in insulin-dependent diabetes, 76
w
N
Nephrectomy, unilateral, diabetic glomerulosclerosis and, 107
Nephropathy Armanni-Ebstein lesion in, genesis of, 2 clinical pattern of, 87 dietary protein and, 37 end-stage, hemodialysis treatment for, in Central
Italy, 4 glomerular sialic acids in, 61
145
146 SUBJECT INDEX
incipient, albuminuria progression in, antihypertensive treatment and, 45
long-term survival and (letter), 33 normoglycemic, 30 pathogenesis of, glomerular filtration and, blood
rheology and, 137 prevention of, 35 progression of, relationship to metabolic control and
blood pressure of, 53 renal biopsy in diabetic with, necessity of, 1 retinopathy incidence and, in Type I diabetes, 96
Nephrotoxicity, of cyclosporine, 128 Non-insulin-dependent diabetes mellitus, s e e Type II
diabetes Normoglycemia, near, effects of, in Type I diabetes, 100 Normoglycemic diabetic nephropathy, 30 Normoglycemic diabetic retinopathy, 30
O
Obese Zucker rat model, of glomerular injury in Type II diabetes, 26
P
Pancreas transplant, renal function after, cyclosporine and, 128
Peritoneal dialysis, continuous ambulatory, s e e Continuous ambulatory peritoneal dialysis
Platelet reactivity, near normoglycemia and, in Type I diabetes, 100
Polycystic kidney disease, adult, with diabetic intercapillary glomerulosclerosis (letter), 32
Protein, dietary, nephropathy and, 37
R
Renal biopsy, necessity of, in nephropathic diabetic, 1 Renal corpuscles, new vessel formation in, advanced
diabetic glomerulopathy and, 122 Renal function
antihypertensive treatment and, 45 continuous subcutaneous insulin infusion and, 91 cyclosporine effect on, in non-uremic diabetic
recipients of pancreas transplants, 128 relationship to metabolic control and blood pressure
of, 53 Renal histopathology, correlation with duration of
diabetes and blood glucose control, 41 Renal hypertrophy, functional aspects of, 7 Renal res,ection, diabetic glomerulosclerosis and, 107 Renal transplant, metabolic control and, 81
Retinopathy clinical nephropathy association with, in Type I
diabetes, 96 normoglycemic, 30
Sialic acids, glomerular, 61 Solid phase enzyme immunoassay, microalbuminuria
detection with, 58
T
Transplant islet, potential of, 115 pancreas, renal function after, cyclosporine and, 128 renal, metabolic control and, 81
Type I diabetes advanced glomerulopathy in, new vessel formation in
renal corpuscles in, 122 antihypertensive treatment and, renal function and,
45 kidney function and size in, continuous subcutaneous
insulin infusion and, 91 kidney transplant and, metabolic control with, 81 microalbuminuria in, 76 near normoglycemia in, 100 nephropathy in
dietary protein and, 37 progression of, 53 -~
pancreas transplant in, cyclosporine effect on native renal function after, 128
Type II diabetes glomerular injury in, obese Zucker model of, 26 maturity onset, microalbuminuria in, 132 renal histopathology, duration of diabetes, and blood
glucose control in, 41 unilatera~ nephrectomy in, diabetic
glomerulosclerosis and, 107
U
Unilateral nephrectomy, diabetic glomerulosclerosis and, 107
Uremia, co-morbidity with, 73 Urinary albumin excretion
antihypertensive treatment and, 45 insulin-dependent diabetes and, 76 maturity onset non-insulin-dependent diabetes
and, 132 measurement of, 58
V
Vitrectomy, 120 V~n Willebrand factor, near normoglycemia and, in
Type I diabetes, 100